当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
オープンアクセスジャーナルはより多くの読者と引用を獲得 700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
特集記事
Biosimilars: Global Acceptance, Importance of Regulatory Consistency and current trends
Translational Oncology Research and its Clinical impact using pioneering examples
Packaging Challenge for Affordable Biosimilar Products
Role of Women in the Study of Analgesic activity of Holarrhena antidysenterica leaves extract
Biomanufacturing Programmes for Early Phase mAb Development
Regulatory Progress of Biosimilars: An Update
in vitro screening of cytotoxic activities of hopea ponga (dennst.) Bark extracts
In Vivo Anti-Inflammatory Activity Of Pajanelia Longifoliabark Extracts
Virtual Behavioural Health Integration into Primary Care – A Clinical Trial
Illegal Trafficking of Banned Drugs of Having Adverse Effect on Human Health.
The Connective Tissue Manipulation as Prevention to Avoid Anti-inflammatories in Musculoskeletal Pain
Financial and Economic Criteria for Evaluating the Performance of Pharmacies
Copyright in Gene Sequences
A Comprehensive and Multidisciplinary Methodology to Improve Biosimilar Uptake in the United States
Comparative Study of Pharmacokinetics and Safety of RPH-001 and Avastin after Single Dose 5mg/kg Given Intravenously to Healthy Male Volunteers
Cage Match: Inter Partes Review and Post Grant Review vs. Biologics and Biosimilars
Biosimilars Interchangeability in the USA: The Final US-FDA Guidance to Industry
Biosimilars Summit & Clinical Trails 2020_Past conference Report